XWEL

XWELL Inc.
NASDAQHEALTHCAREDIAGNOSTICS & RESEARCH

Key Statistics

Market Cap
$7.68M
P/E Ratio
—
EPS
$-5.21
Beta
1.00
52W High
$2.20
52W Low
$0.26
50-Day MA
$0.98
200-Day MA
$0.98
Dividend Yield
—
Profit Margin
-82.90%
Forward P/E
10.79
PEG Ratio
—

About XWELL Inc.

XWELL Inc., a health and wellness services company, provides spa services at airports. The company is headquartered in New York, New York.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$28.28M
Gross Profit (TTM)$9.71M
EBITDA$-9.94M
Operating Margin-26.10%
Return on Equity-361.40%
Return on Assets-31.40%
Revenue/Share (TTM)$4.12
Book Value$-0.22
Price-to-Book20.33
Price-to-Sales (TTM)0.27
EV/Revenue0.115
EV/EBITDA0.47
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)-7.10%
Shares Outstanding$8.59M
Float$5.81M
% Insiders27.11%
% Institutions16.82%

Historical Volatility

HV 10-Day
26.31%
HV 20-Day
47.47%
HV 30-Day
55.56%
HV 60-Day
73.40%
HV Rank
—

Volatility is currently contracting

Latest News

XWELL Appoints Global Energy and Capital Markets Leader Gerard Reid to its Board of Directors

NEW YORK, Aug. 05, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (the "Company" or “XWELL”) (NASDAQ: XWEL), today announced the appointment of Gerard Reid to its Board of Directors, effective immediately. The Company also announced that Ezra Ernst has resigned as a director from the Board of Directors to focus on his responsibilities as President and Chief Executive Officer.

GlobeNewsWire8/5/2026Neutral
XWELL Announces Definitive Agreement to Divest XpresSpa and XpresTest Businesses

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), a provider of wellness and biosecurity solutions, and Face Haus, LLC (“Face Haus”), a leading skincare service and product business, today announced that the Company has entered into a definitive agreement with an affiliate of Face Haus, Express Wellness Group, LLC, under which XWELL will divest its XpresSpa Holdings, LLC and XpresTest, Inc. businesses for $13 million, subject to certain closing adjustments.

GlobeNewsWire7/7/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on XWEL and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 9/28/2026